MDMX Contains an Autoinhibitory Sequence Element

Total Page:16

File Type:pdf, Size:1020Kb

MDMX Contains an Autoinhibitory Sequence Element MDMX contains an autoinhibitory sequence element Michal Bista, Miriana Petrovich, and Alan R. Fersht1 Medical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom Contributed by Alan R. Fersht, September 14, 2013 (sent for review August 28, 2013) MDM2 and MDMX are homologous proteins that bind to p53 and Results regulate its activity. Both contain three folded domains and ∼70% MDMX Reversibly Dimerizes. MDMX was expressed in Escherichia intrinsically disordered regions. Previous detailed structural and coli and purified to homogeneity using standard methods (12, biophysical studies have concentrated on the isolated folded 21). We found by size-exclusion chromatography (SEC) that fi domains. The N-terminal domains of both exhibit high af nity the protein eluted at volumes typical for ∼400-kDa globular for the disordered N-terminal of p53 (p53TAD) and inhibit its trans- proteins, much earlier than expected from a monomeric 55- activation function. Here, we have studied full-length MDMX and kDa molecule (Fig. 1A). The elution volume was concentration ∼ fi found a 100-fold weaker af nity for p53TAD than does its iso- dependent, suggesting that the protein was undergoing a re- lated N-terminal domain. We found from NMR spectroscopy and versible oligomerization. Multiangle light scattering (MALS) binding studies that MDMX (but not MDM2) contains a conserved, analysis yielded molecular weight of the eluted protein fraction disordered self-inhibitory element that competes intramolecularly to be ∼100–110 kDa, in agreement with a dimer (110 kDa)– for binding with p53TAD. This motif, which we call the WWW monomer (55 kDa) equilibrium. We used analytical ultracen- element, is centered around residues Trp200 and Trp201. Deletion trifugation to find the dimerization K to be 1.12 ± 0.18 μM or mutation of the element increased binding affinity of MDMX to d that of the isolated N-terminal domain level. The self-inhibition of (Fig. S2). C-terminally truncated mutants of MDMX were ex- MDMX implies a regulatory, allosteric mechanism of its activity. clusively monomeric, showing that the RING domain was es- MDMX rests in a latent state in which its binding activity with sential for dimerization. p53TAD is masked by autoinhibition. Activation of MDMX would MDMX Binds to p53. We mixed MDMX with tetrameric p53 and require binding to a regulatory protein. The inhibitory function of the WWW element may explain the oncogenic effects of an alter- subjected the complexes to SEC-MALS analysis. Their sizes were dependent on the stoichiometry, reaching maximal values native splicing variant of MDMX that does not contain the WWW ∼ element and is found in some aggressive cancers. of 400 kDa for equimolar mixtures, which corresponded to octamers built of four MDMX and four p53 subunits (Fig. 1A). fl MDM4 | HDMX | MDMX-S | IDP | TROSY Interestingly, even though interaction of exible, multivalent receptor–ligand pairs (like MDMX and p53) could potentially lead to formation of high–molecular-weight polymers (22), we he homologous proteins MDMX and MDM2 are major found a size cap of 400 kDa that was preserved even at high negative regulators of the level of p53 and its activity in T ratios of MDMX to p53 and vice versa. normal cells. They are frequently up-regulated in many types of – cancers, becoming oncogenes (1 3). Both proteins bind to the MDMX Stimulates Ubiquitination. SEC-MALS analysis confirmed transactivation domain of p53 (p53TAD) and inhibit its in- that the recombinant MDMX contained functional NTD (re- teraction with transcriptional cofactors. In addition, MDM2 is an sponsible for p53 binding) and C-terminal RING domain capa- E3 ubiquitin ligase with a catalytically active RING domain and ble of homodimerization. To confirm the biochemical activity of can target p53 for proteosomal degradation (4). MDMX has an recombinant proteins, we performed an in vitro ubiquitination inactive RING domain but can efficiently inhibit the p53 activity, assay. MDMX did not exhibit intrinsic E3 ligase activity, and either independently [e.g., in the vast majority of primary mel- MDM2 was only weakly active. Mixing the two recombinant anomas (5)] or in association with MDM2 by boosting its E3 proteins yielded a highly active complex capable of performing ligase activity (6). Both proteins are vital for homeostasis, and knockout of either of them in mice models results in p53-dependent Significance lethality, with survival times longer for MDMX deficiency (3). MDM2 and MDMX are intrinsically disordered proteins, each The protein MDMX is an important negative regulator of the with three folded domains (Fig. S1A). The structures of the tumor suppressor p53 in normal cells and can become a pow- isolated domains have been elucidated at atomic resolution (Fig. erful oncogene. Previous studies on isolated protein fragments S1 B–D): the N-terminal, globular SWIB-like domain (NTD) established that the N-terminal domain of MDMX binds tightly binds to the p53 transactivation domain p53TAD (7, 8) [with to the N-terminal domain of p53 and inhibits it. We now find W23p53 contributing the most interaction energy (9, 10)]; the that full-length MDMX contains a regulatory element (the central part of the protein contains a RanBP2 type zinc finger “WWW element”) that binds to its own N-terminal domain and (ref. 11 and PDB ID code 2CR8) and the C terminus is a RING- prevents MDMX from binding to p53. This autoinhibition type ubiquitin ligase domain, which tends to associate and form introduces a new level of regulation of MDMX, whereby ac- homodimers and heterodimers and higher-order oligomers (12, cessory proteins may sequester the WWW sequence and 13). There are specific MDM2 inhibitors that bind to the NTD reactivate MDMX, and may explain why a variant of MDMX [e.g., nutlin-3 (14)], which usually have lower potency against that lacks the WWW sequence, which is found in some cancer cells, might be oncogenic. MDMX (8). The most oncogenic form of these proteins is the – – MDM2 MDMX heterodimer (3, 15 17). Author contributions: M.B., M.P., and A.R.F. designed research; M.B. and M.P. performed There are few detailed biophysical and structural studies on research; M.B. and M.P. analyzed data; and M.B. and A.R.F. wrote the paper. the full-length proteins and how the individual domains interact The authors declare no conflict of interest. – fi (18 21). Here, we analyze MDMX and nd that there is a reg- 1To whom correspondence should be addressed. E-mail: [email protected]. ulatory autoinhibitory sequence within MDMX that regulates its This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. binding characteristics with p53, with biological implications. 1073/pnas.1317398110/-/DCSupplemental. 17814–17819 | PNAS | October 29, 2013 | vol. 110 | no. 44 www.pnas.org/cgi/doi/10.1073/pnas.1317398110 Downloaded by guest on September 30, 2021 +MDMX MDM2 MDMX MDM2 A B Molecular weight [kDa] μ μ 160 kDa μ μμ 110 kDa 80 kDa A280 (relative) 60 kDa 50 kDa Elution time [min] Fig. 1. MDMX is dimer capable of stimulating E3 activity of MDM2. (A) SEC-MALS analysis of MDMX and p53; A280 chromatograms were scaled to give the same peak heights. Masses calculated from the static light scattering are shown as thick lines. Composition of samples subjected to the analysis described in the legend. (B) Enzymatic activity of recombinant proteins; in vitro ubiquitination reactions were resolved by denaturing electrophoresis and immunoblotted with anti-ubiquitin antibodies, which recognize polyubiquitinated forms more strongly than monoubiquitinated (see Fig. S3 for detection using other antibodies). polyubiquitination (Fig. 1B). The results of the in vitro assay NTD Interacts Intramolecularly with a Conserved “WWW Element.” performed with recombinant proteins were in good agreement The spectral changes in the NTD and flexible linkers sug- with the previously reported activities of endogenous proteins in gested that the p53TAD displaces an intramolecular interaction cellular context (6); we found that MDMX stimulated both of the NTD with a segment of MDMX, releasing Trp residues. autoubiquitination of MDM2–MDMX complex and p53 ubiq- Basing on observing that three tryptophans were involved and uitination (Fig. S3) (23). primary sequence analysis, we hypothesized that the interaction might involve a tryptophan-rich segment within residues 190– NMR Spectra of MDMX. We labeled the full-length MDMX with 210 (190FEEWDVAGLPWWFLGNLRSNY210, which we call 15N and recorded a transverse relaxation-optimized spectroscopy the WWW element). Notably, the element is specifictoMDMX, (TROSY) spectrum. The spectrum shown in Fig. 2A was domi- as the corresponding region of MDM2 contains an unrelated nated by signals from highly flexible, intrinsically disordered sequence (Fig. 3A). 15 linkers. Such appearance, with majority of resonances occupying To verify binding of the segment experimentally, we N-labeled the central part of the spectrum is typical of intrinsically dis- the WWW-containing peptide (181–209) and titrated it with – ordered proteins. In addition to these signals from disordered the isolated NTD. The NTD WWW interaction was strong linkers, we could also identify a range of broader and more dis- enough to occur between isolated domains that were not perse resonances originating from the folded NTD and RanBP2 covalently linked. Numerous resonances of the WWW were domains. The absence of RING signals from the spectrum was broadened on binding. We assigned the heteronuclear single- anticipated because in multidomain proteins with intrinsically quantum coherence (HSQC) spectrum of the WWW construct andmappedtheinteractionsitetoaminoacids194–206 (Fig. disordered linkers, central domains are frequently more con- B C strained rotationally than structures located distally (24, 25). 3 and ). Interestingly, the WWW element remained in the fi intermediate timescale of chemical exchange in excess of There were unexpected signi cant differences between the – spectra of the NTD in full-length protein and the isolated MDMX NTD.
Recommended publications
  • HSF-1 Activates the Ubiquitin Proteasome System to Promote Non-Apoptotic
    HSF-1 Activates the Ubiquitin Proteasome System to Promote Non-Apoptotic Developmental Cell Death in C. elegans Maxime J. Kinet#, Jennifer A. Malin#, Mary C. Abraham, Elyse S. Blum, Melanie Silverman, Yun Lu, and Shai Shaham* Laboratory of Developmental Genetics The Rockefeller University 1230 York Avenue New York, NY 10065 USA #These authors contributed equally to this work *To whom correspondence should be addressed: Tel (212) 327-7126, Fax (212) 327- 7129, email [email protected] Kinet, Malin et al. Abstract Apoptosis is a prominent metazoan cell death form. Yet, mutations in apoptosis regulators cause only minor defects in vertebrate development, suggesting that another developmental cell death mechanism exists. While some non-apoptotic programs have been molecularly characterized, none appear to control developmental cell culling. Linker-cell-type death (LCD) is a morphologically conserved non-apoptotic cell death process operating in C. elegans and vertebrate development, and is therefore a compelling candidate process complementing apoptosis. However, the details of LCD execution are not known. Here we delineate a molecular-genetic pathway governing LCD in C. elegans. Redundant activities of antagonistic Wnt signals, a temporal control pathway, and MAPKK signaling control HSF-1, a conserved stress-activated transcription factor. Rather than protecting cells, HSF-1 promotes their demise by activating components of the ubiquitin proteasome system, including the E2 ligase LET- 70/UBE2D2 functioning with E3 components CUL-3, RBX-1, BTBD-2, and SIAH-1. Our studies uncover design similarities between LCD and developmental apoptosis, and provide testable predictions for analyzing LCD in vertebrates. 2 Kinet, Malin et al. Introduction Animal development and homeostasis are carefully tuned to balance cell proliferation and death.
    [Show full text]
  • Defining Functional Interactions During Biogenesis of Epithelial Junctions
    ARTICLE Received 11 Dec 2015 | Accepted 13 Oct 2016 | Published 6 Dec 2016 | Updated 5 Jan 2017 DOI: 10.1038/ncomms13542 OPEN Defining functional interactions during biogenesis of epithelial junctions J.C. Erasmus1,*, S. Bruche1,*,w, L. Pizarro1,2,*, N. Maimari1,3,*, T. Poggioli1,w, C. Tomlinson4,J.Lees5, I. Zalivina1,w, A. Wheeler1,w, A. Alberts6, A. Russo2 & V.M.M. Braga1 In spite of extensive recent progress, a comprehensive understanding of how actin cytoskeleton remodelling supports stable junctions remains to be established. Here we design a platform that integrates actin functions with optimized phenotypic clustering and identify new cytoskeletal proteins, their functional hierarchy and pathways that modulate E-cadherin adhesion. Depletion of EEF1A, an actin bundling protein, increases E-cadherin levels at junctions without a corresponding reinforcement of cell–cell contacts. This unexpected result reflects a more dynamic and mobile junctional actin in EEF1A-depleted cells. A partner for EEF1A in cadherin contact maintenance is the formin DIAPH2, which interacts with EEF1A. In contrast, depletion of either the endocytic regulator TRIP10 or the Rho GTPase activator VAV2 reduces E-cadherin levels at junctions. TRIP10 binds to and requires VAV2 function for its junctional localization. Overall, we present new conceptual insights on junction stabilization, which integrate known and novel pathways with impact for epithelial morphogenesis, homeostasis and diseases. 1 National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK. 2 Computing Department, Imperial College London, London SW7 2AZ, UK. 3 Bioengineering Department, Faculty of Engineering, Imperial College London, London SW7 2AZ, UK. 4 Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.
    [Show full text]
  • UBE2B Sirna Set I Sirna Duplexes Targeted Against Three Exon Regions
    Catalog # Aliquot Size U211-911-05 3 x 5 nmol U211-911-20 3 x 20 nmol U211-911-50 3 x 50 nmol UBE2B siRNA Set I siRNA duplexes targeted against three exon regions Catalog # U211-911 Lot # Z2109-16 Specificity Formulation UBE2B siRNAs are designed to specifically knock-down The siRNAs are supplied as a lyophilized powder and human UBE2B expression. shipped at room temperature. Product Description Reconstitution Protocol UBE2B siRNA is a pool of three individual synthetic siRNA Briefly centrifuge the tubes (maximum RCF 4,000g) to duplexes designed to knock-down human UBE2B mRNA collect lyophilized siRNA at the bottom of the tube. expression. Each siRNA is 19-25 bases in length. The gene Resuspend the siRNA in 50 µl of DEPC-treated water accession number is NM_003337. (supplied by researcher), which results in a 1x stock solution (10 µM). Gently pipet the solution 3-5 times to mix Gene Aliases and avoid the introduction of bubbles. Optional: aliquot E2-17kDa; HHR6B; HR6B; RAD6B; UBC2 1x stock solutions for storage. Storage and Stability Related Products The lyophilized powder is stable for at least 4 weeks at room temperature. It is recommended that the Product Name Catalog Number lyophilized and resuspended siRNAs are stored at or UBE2A Protein U210-30H below -20oC. After resuspension, siRNA stock solutions ≥2 UBE2B Protein U211-30H µM can undergo up to 50 freeze-thaw cycles without UBE2C Protein U212-30H significant degradation. For long-term storage, it is UBE2D1 (UBCH5A) U213-30H recommended that the siRNA is stored at -70oC. For most Protein favorable performance, avoid repeated handling and UBE2D2 (UBC4) Protein U214-30H multiple freeze/thaw cycles.
    [Show full text]
  • HSF-1 Activates the Ubiquitin Proteasome System to Promote Non-Apoptotic Developmental Cell Death in C. Elegans
    RESEARCH ARTICLE HSF-1 activates the ubiquitin proteasome system to promote non-apoptotic developmental cell death in C. elegans Maxime J Kinet†, Jennifer A Malin†, Mary C Abraham, Elyse S Blum, Melanie R Silverman, Yun Lu, Shai Shaham* Laboratory of Developmental Genetics, The Rockefeller University, New York, United States Abstract Apoptosis is a prominent metazoan cell death form. Yet, mutations in apoptosis regulators cause only minor defects in vertebrate development, suggesting that another developmental cell death mechanism exists. While some non-apoptotic programs have been molecularly characterized, none appear to control developmental cell culling. Linker-cell-type death (LCD) is a morphologically conserved non-apoptotic cell death process operating in Caenorhabditis elegans and vertebrate development, and is therefore a compelling candidate process complementing apoptosis. However, the details of LCD execution are not known. Here we delineate a molecular-genetic pathway governing LCD in C. elegans. Redundant activities of antagonistic Wnt signals, a temporal control pathway, and mitogen-activated protein kinase kinase signaling control heat shock factor 1 (HSF-1), a conserved stress-activated transcription factor. Rather than protecting cells, HSF-1 promotes their demise by activating components of the ubiquitin proteasome system, including the E2 ligase LET-70/UBE2D2 functioning with E3 components CUL-3, RBX-1, BTBD-2, and SIAH-1. Our studies uncover design similarities between *For correspondence: shaham@ LCD and developmental apoptosis, and provide testable predictions for analyzing LCD in rockefeller.edu vertebrates. †These authors contributed DOI: 10.7554/eLife.12821.001 equally to this work Competing interests: The authors declare that no competing interests exist. Introduction Animal development and homeostasis are carefully tuned to balance cell proliferation and death.
    [Show full text]
  • Characterization of the Cellular Network of Ubiquitin Conjugating and Ligating Enzymes Ewa Katarzyna Blaszczak
    Characterization of the cellular network of ubiquitin conjugating and ligating enzymes Ewa Katarzyna Blaszczak To cite this version: Ewa Katarzyna Blaszczak. Characterization of the cellular network of ubiquitin conjugating and ligating enzymes. Cellular Biology. Université Rennes 1, 2015. English. NNT : 2015REN1S116. tel-01547616 HAL Id: tel-01547616 https://tel.archives-ouvertes.fr/tel-01547616 Submitted on 27 Jun 2017 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. ANNÉE 2015 THÈSE / UNIVERSITÉ DE RENNES 1 sous le sceau de l’Université Européenne de Bretagne pour le grade de DOCTEUR DE L’UNIVERSITÉ DE RENNES 1 Mention : BIOLOGIE École doctorale Vie-Agro-Santé présentée par Ewa Katarzyna Blaszczak Préparée à l’unité de recherche UMR 6290, IGDR Institut de Génétique et Développement de Rennes Université Rennes 1 Thèse soutenue à Rennes le 26.06.2015 Characterization of devant le jury composé de : Aude ECHALIER-GLAZER the cellular network Maître de conférence University of Leicester / rapporteur of ubiquitin Lionel PINTARD Directeur de recherche
    [Show full text]
  • Ubiquitin-Conjugating Enzyme UBE2D2 Is Responsible for FBXW2
    BIOLOGY OF REPRODUCTION 79, 914–920 (2008) Published online before print 13 August 2008. DOI 10.1095/biolreprod.108.071407 Ubiquitin-Conjugating Enzyme UBE2D2 Is Responsible for FBXW2 (F-Box and WD Repeat Domain Containing 2)-Mediated Human GCM1 (Glial Cell Missing Homolog 1) Ubiquitination and Degradation1 Meng-Hsiu Chiang,3,4 Liang-Fu Chen,3,4 and Hungwen Chen2,4,5 Graduate Institute of Biochemical Sciences,4 National Taiwan University, Taipei 106, Taiwan Institute of Biological Chemistry,5 Academia Sinica, Taipei 115, Taiwan ABSTRACT lysine in a target protein. To begin the process, a ubiquitin molecule is activated by the E1 ubiquitin-activating enzyme to Glial cell missing homolog 1 (GCM1) is an important form a high-energy thioester intermediate with E1. The transcription factor regulating placental cell fusion. Recently, activated ubiquitin molecule is then transferred to an E2 we have demonstrated that GCM1 is a labile protein and that the ubiquitin-conjugating enzyme to form a high-energy thioester F-box protein FBXW2 (F-box and WD repeat domain containing intermediate with E2. Finally, association of this charged E2 2) mediates GCM1 ubiquitination for proteasomal degradation. with an E3 ubiquitin-protein ligase facilitates the conjugation Multiple factors are involved in the ubiquitin-proteasome of the ubiquitin molecule to the target protein, which is degradation system. Therefore, in order to better understand specifically recognized by one of many different E3 enzymes the mechanism regulating GCM1 stability, we further isolated and characterized the E2 ubiquitin-conjugating enzyme respon- [1, 2]. When the target protein is polyubiquitinated, it is sible for FBXW2-mediated ubiquitination of GCM1 in this study.
    [Show full text]
  • Protein Engineering of a Ubiquitin-Variant Inhibitor of APC/C Identifies a Cryptic K48 Ubiquitin Chain Binding Site
    Protein engineering of a ubiquitin-variant inhibitor of APC/C identifies a cryptic K48 ubiquitin chain binding site Edmond R. Watsona,b, Christy R. R. Gracea, Wei Zhangc,d,2, Darcie J. Millera, Iain F. Davidsone, J. Rajan Prabub, Shanshan Yua, Derek L. Bolhuisf, Elizaveta T. Kulkof, Ronnald Vollrathb, David Haselbache,g, Holger Starkg, Jan-Michael Peterse,h, Nicholas G. Browna,f, Sachdev S. Sidhuc,1, and Brenda A. Schulmana,b,1 aDepartment of Structural Biology, St. Jude Children’s Research Hospital, Memphis, TN 38105; bDepartment of Molecular Machines and Signaling, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany; cDonnelly Centre for Cellular and Biomolecular Research, Banting and Best Department of Medical Research, University of Toronto, Toronto, ON, Canada M5S3E1; dDepartment of Molecular Genetics, University of Toronto, Toronto, ON, Canada M5S3E1; eResearch Institute of Molecular Pathology, Vienna BioCenter, 1030 Vienna, Austria; fDepartment of Pharmacology and Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599; gMax Planck Institute for Biophysical Chemistry, 37077 Göttingen, Germany; and hMedical University of Vienna, 1090 Vienna, Austria Contributed by Brenda A. Schulman, June 24, 2019 (sent for review February 19, 2019; reviewed by Kylie Walters and Hao Wu) Ubiquitin (Ub)-mediated proteolysis is a fundamental mechanism the type of catalytic domain. E3s harboring “HECT” and “RBR” used by eukaryotic cells to maintain homeostasis and protein catalytic domains promote ubiquitylation through 2-step reac- quality, and to control timing in biological processes. Two essential tions involving formation of a thioester-linked intermediate be- aspects of Ub regulation are conjugation through E1-E2-E3 enzy- tween the E3 and Ub’s C terminus: First, Ub is transferred from matic cascades and recognition by Ub-binding domains.
    [Show full text]
  • Ubiquitylation of P62/Sequestosome1 Activates Its Autophagy Receptor Function and Controls Selective Autophagy Upon Ubiquitin Stress
    Cell Research (2017) 27:657-674. © 2017 IBCB, SIBS, CAS All rights reserved 1001-0602/17 $ 32.00 ORIGINAL ARTICLE www.nature.com/cr Ubiquitylation of p62/sequestosome1 activates its autophagy receptor function and controls selective autophagy upon ubiquitin stress Hong Peng1, 2, 3, *, Jiao Yang1, 2, 3, *, Guangyi Li1, 2, Qing You1, 2, Wen Han1, Tianrang Li1, Daming Gao1, Xiaoduo Xie1, Byung-Hoon Lee4, Juan Du5, Jian Hou5, Tao Zhang6, Hai Rao7, Ying Huang3, Qinrun Li1, Rong Zeng1, Lijian Hui3, Hongyan Wang1, Qin Xia8, Xuemin Zhang8, Yongning He3, Masaaki Komatsu9, Ivan Dikic10, Daniel Finley4, Ronggui Hu1 1Key Laboratory of Systems Biology, CAS Center for Excellence in Molecular Cell Science, Innovation Center for Cell Signaling Network, 2Graduate School, University of Chinese Academy of Sciences; 3Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China; 4Department of Cell Biology, Harvard Medical School, 240 Longwood Ave, Boston, MA 02115, USA; 5Department of Hematology, Changzheng Hospital, The Second Military Medical University, 415 Fengyang Road, Shanghai 200003, China; 6Department of Laboratory Medicine, Huashan Hospital, Fudan University, 12 Central Urumqi Road, Shanghai 200040, China; 7Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA; 8State Key Laboratory of Proteomics, National Center of Biomedical Analysis, Institute of Basic Medical Sciences, Beijing 100850, China; 9Department of Biochemistry, School of Medicine Niigata University, 757, Ichibancho, Asahimachidori, Chuo-ku, Niigata 951-8510, Japan; 10Molecular Signaling, Institute of Biochemistry II, Goethe University School of Medicine, 60590 Frankfurt am Main, Germany Alterations in cellular ubiquitin (Ub) homeostasis, known as Ub stress, feature and affect cellular responses in multiple conditions, yet the underlying mechanisms are incompletely understood.
    [Show full text]
  • Identification of Prognosis Biomarkers of Prostatic Cancer in a Cohort Of
    Current Problems in Cancer 43 (2019) 100503 Contents lists available at ScienceDirect Current Problems in Cancer journal homepage: www.elsevier.com/locate/cpcancer Identification of prognosis biomarkers of prostatic cancer in a cohort of 498 patients from TCGA ∗ Zhiqiang Chen , Haiyi Hu Department of Urology, Sir Run Run Shaw Hospital, Medical College of Zhejiang University, Hangzhou, China a b s t r a c t Objective: Prostatic cancer (PCa) is the first common cancer in male, and the prognostic variables are ben- eficial for clinical trial design and treatment strategies for PCa. This study was performed to identify more potential biomarkers for the prognosis of patients with PCa. Methods and results: The transcriptome data and survival information of a cohort including 498 subjects with PCa were downloaded from TCGA . A total of 4293 differentially expressed genes (DEGs), including 1362 prognosis-related DEGs, were identified in PCa tissues compared with normal tissues. Upregulated genes, including serine/arginine-rich splicing factors (SRSFs; such as SRSF2, SRSF5, SRSF7 and SRSF8 ), and ubiquitin conjugating enzyme E2 (UBE2) members (such as UBE2D2, UBE2G2, UBE2J1 and UBE2E1 ), were identified as negative prognostic biomarkers of PCa, as the high expression of them correlated with poor overall survival of PCa patients. Several downregulated Golgi-ER traffic mediators (such as SEC31A, TMED2, and TMED10 ) were identified as positive prognostic biomarkers of PCa, as the high expression of them correlated with good overall survival of PCa patients. Conclusions: These genes were of great interests in prognosis of PCa, and some of them may be constructive for the augmentation of clinical trial design and treatment strategies for PCa.
    [Show full text]
  • Comparative Analysis of the Ubiquitin-Proteasome System in Homo Sapiens and Saccharomyces Cerevisiae
    Comparative Analysis of the Ubiquitin-proteasome system in Homo sapiens and Saccharomyces cerevisiae Inaugural-Dissertation zur Erlangung des Doktorgrades der Mathematisch-Naturwissenschaftlichen Fakultät der Universität zu Köln vorgelegt von Hartmut Scheel aus Rheinbach Köln, 2005 Berichterstatter: Prof. Dr. R. Jürgen Dohmen Prof. Dr. Thomas Langer Dr. Kay Hofmann Tag der mündlichen Prüfung: 18.07.2005 Zusammenfassung I Zusammenfassung Das Ubiquitin-Proteasom System (UPS) stellt den wichtigsten Abbauweg für intrazelluläre Proteine in eukaryotischen Zellen dar. Das abzubauende Protein wird zunächst über eine Enzym-Kaskade mit einer kovalent gebundenen Ubiquitinkette markiert. Anschließend wird das konjugierte Substrat vom Proteasom erkannt und proteolytisch gespalten. Ubiquitin besitzt eine Reihe von Homologen, die ebenfalls posttranslational an Proteine gekoppelt werden können, wie z.B. SUMO und NEDD8. Die hierbei verwendeten Aktivierungs- und Konjugations-Kaskaden sind vollständig analog zu der des Ubiquitin- Systems. Es ist charakteristisch für das UPS, daß sich die Vielzahl der daran beteiligten Proteine aus nur wenigen Proteinfamilien rekrutiert, die durch gemeinsame, funktionale Homologiedomänen gekennzeichnet sind. Einige dieser funktionalen Domänen sind auch in den Modifikations-Systemen der Ubiquitin-Homologen zu finden, jedoch verfügen diese Systeme zusätzlich über spezifische Domänentypen. Homologiedomänen lassen sich als mathematische Modelle in Form von Domänen- deskriptoren (Profile) beschreiben. Diese Deskriptoren können wiederum dazu verwendet werden, mit Hilfe geeigneter Verfahren eine gegebene Proteinsequenz auf das Vorliegen von entsprechenden Homologiedomänen zu untersuchen. Da die im UPS involvierten Homologie- domänen fast ausschließlich auf dieses System und seine Analoga beschränkt sind, können domänen-spezifische Profile zur Katalogisierung der UPS-relevanten Proteine einer Spezies verwendet werden. Auf dieser Basis können dann die entsprechenden UPS-Repertoires verschiedener Spezies miteinander verglichen werden.
    [Show full text]
  • The N-Terminal Extension of UBE2E Ubiquitin-Conjugating Enzymes Limits Chain Assembly
    View metadata, citation and similar papers at core.ac.uk brought to youFeatured by CORE provided by Elsevier - PublisherArcle Connector The N-Terminal Extension of UBE2E Ubiquitin-Conjugating Enzymes Limits Chain Assembly Frances-Rose Schumacher, Georgina Wilson and Catherine L. Day Biochemistry Department, University of Otago, Dunedin 9054, New Zealand Correspondence to Catherine L. Day: [email protected] http://dx.doi.org/10.1016/j.jmb.2013.06.039 Edited by S. Khorasanizadeh Abstract Protein ubiquitylation depends upon the concerted action of ubiquitin-conjugating enzymes (E2s) and ubiquitin ligases (E3s). All E2s have a conserved ubiquitin-conjugating (UBC) domain but many have variable extensions N- and C-terminal to the UBC domain. For many E2s, the function of the extension is not well understood. Here, we show that the N-terminal extension of the UBE2E proteins regulates formation of polyubiquitin chains by the processive UBC domain. Target proteins are therefore mono- ubiquitylated by full-length UBE2E, whereas the UBC domain alone polyubiquitylates proteins. Although the N-terminal extension of UBE2E1 is largely disordered in solution, these residues have acriticalroleinlimitingchainbuilding,andwhen fused to the highly processive E2, UBE2D2, ubiquitylation is limited. For some E2s, interaction of ubiquitin with the ‘backside’ of the UBC domain Legend: Some ubiquitin-conjugating enzymes (E2s) com- promotes polyubiquitylation. However, interaction of prise just the conserved core domain, whereas others such ubiquitin with the backside of the UBC domain of as the UBE2E family have an N-terminal extension. Here, UBE2E1 does not appear to be important for we show that the core domain can build chains but the processivity.
    [Show full text]
  • Anti-UBE2D2 (Aa 99-147) Polyclonal Antibody (DPABH-17109) This Product Is for Research Use Only and Is Not Intended for Diagnostic Use
    Anti-UBE2D2 (aa 99-147) polyclonal antibody (DPABH-17109) This product is for research use only and is not intended for diagnostic use. PRODUCT INFORMATION Antigen Description Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro catalyzes Lys-48-linked polyubiquitination. Mediates the selective degradation of short-lived and abnormal proteins. Functions in the E6/E6-AP-induced ubiquitination of p53/TP53. Mediates ubiquitination of PEX5 and autoubiquitination of STUB1 and TRAF6. Involved in the signal- induced conjugation and subsequent degradation of NFKBIA, FBXW2-mediated GCM1 ubiquitination and degradation, MDM2-dependent degradation of p53/TP53 and the activation of MAVS in the mitochondria by DDX58/RIG-I in response to viral infection. Essential for viral activation of IRF3. Immunogen A region within synthetic peptide: ISKVLLSICS LLCDPNPDDP LVPEIARIYK TDREKYNRIA REWTQKYAM, corresponding to C terminal amino acids 99-147 of Human UBE2D2 Isotype IgG Source/Host Rabbit Species Reactivity Mouse, Rat, Dog, Human Purification Protein A purified Conjugate Unconjugated Applications WB, ELISA, IHC-P Format Liquid Size 100 μl Buffer Constituents: 2% Sucrose, PBS Preservative None Storage Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles. GENE INFORMATION 45-1 Ramsey Road, Shirley, NY 11967, USA Email: [email protected] Tel: 1-631-624-4882 Fax: 1-631-938-8221 1 © Creative Diagnostics All Rights Reserved Gene Name UBE2D2 ubiquitin-conjugating
    [Show full text]